Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide)...
Read more
Johnson & Johnson announced that Janssen Vaccines & Prevention BV, part of the Janssen Pharmaceutical Companies, is working in partnership...
Read more
Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic...
Read more
DNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced the intratumoral delivery of DNX-2401 to the...
Read more
Bayer has extended its ongoing research collaboration with the Broad Institute of MIT and Harvard in the US by five...
Read more
AMPEL BioSolutions, a leading biomedical research firm based in Charlottesville, Va., Horizon Pharma plc and The Lupus Research Alliance today...
Read more
The European Investment Bank (EIB) and Grifols signed an Euros 85 million loan to support the company's R+D+i initiatives focused...
Read more
Sunovion Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala™...
Read more
AstraZeneca has announced positive top-line results of the phase IV ASCENT trial for Tudorza Pressair (aclidinium bromide 400 µg, twice-daily),...
Read more
Introducing a new disease-modifying therapy, from research through to launch, is an extremely complex process, with lengthy and expensive drug...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
